Skip to main content
. 2021 Feb;13(2):1083–1089. doi: 10.21037/jtd-20-2082

Table 3. Post-operative factors associated with post-CABG pleural effusion.

Variable Pleural effusion drainage group
(n=59)
No pleural effusion drainage group (n=350) P value
Red cell transfusion post-operatively 27 (45.8%) 126 (36.0%) 0.15
Non-red cell blood products transfused post-operatively 17 (28.8%) 57 (16.3%) 0.02*
Drain outputs first 4 hours (mL) 232.47±291.26 214.67±153.73 0.48
Early return to theatre for bleeding 3 (5.1%) 12 (3.4%) 0.46
Duration of time intubated (hours) 29.44±87.49 11.52±14.55 <0.01*
Time to extubation (hours) 29.44±87.5 11.5±14.6 <0.01*
Prolonged ventilation (>24 hours) 9 (15.3%) 19 (5.4%) <0.01*
Reintubation 6 (10.2%) 13 (3.7%) 0.03*
ICU length of stay (days) 4.87±4.77 4.14±6.95 0.44
Return to ICU 9 (15.3%) 15 (4.3%) <0.01*
Highest post-operative creatinine (micromol/L) 151.39±173.56 113.48±92.53 0.01*
Lowest post-operative haemoglobin (gram/L) 80.56±12.14 84.80±14.88 0.04*
Pericarditis 6 (10.2%) 29 (8.3%) 0.63
New post-op arrhythmia 28 (57.1% of those without pre-op AF) 111 (34.4% of those without pre-op AF) <0.01*
New post-op renal failure 5 (8.5%) 6 (1.7%) <0.01*
Peri-operative myocardial infarct 0 (0.0%) 1 (0.3%) ~1
Post-operative pneumonia 3 (5.1%) 13 (3.7%) 0.71
Deep sternal wound infection 3 (5.1%) 4 (1.1%) 0.07
Pericardial effusion requiring drainage 7 (11.9%) 1 (0.3%) <0.01*
Maximum post-operative weight gain (kg) 7.58±3.68 5.89±3.30 <0.01*
Mortality 2 (3.4%) 3 (0.9%) 0.15
Length of stay (post-op) (days) 15.25±10.47 8.93±6.77 <0.01*
Readmission 10 (16.9%) 28 (8.0%) 0.03*

*, statistically significant P value <0.05. CABG, coronary artery bypass grafting.